Kleanthis G. Xanthopoulos
2015 - Regulus Therapeutics
In 2015, Kleanthis G. Xanthopoulos earned a total compensation of $3M as Former President Chief Executive Officer at Regulus Therapeutics, a 22% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,752,311 |
|---|---|
| Salary | $267,933 |
| Other | $1,029,016 |
| Total | $3,049,260 |
Xanthopoulos received $1.8M in option awards, accounting for 57% of the total pay in 2015.
Xanthopoulos also received $267.9K in salary and $1M in other compensation.
Rankings
In 2015, Kleanthis G. Xanthopoulos' compensation ranked 3,119th out of 13,638 executives tracked by ExecPay. In other words, Xanthopoulos earned more than 77.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,119 out of 13,638 | 77th |
Division Manufacturing | 1,113 out of 5,187 | 79th |
Major group Chemicals And Allied Products | 408 out of 1,857 | 78th |
Industry group Drugs | 321 out of 1,531 | 79th |
Industry Pharmaceutical Preparations | 256 out of 1,179 | 78th |
Source: SEC filing on April 22, 2016.
Xanthopoulos' colleagues
We found three more compensation records of executives who worked with Kleanthis G. Xanthopoulos at Regulus Therapeutics in 2015.